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Introduction: Pain to balloon time could have significant error
due to often imprecise pain onset time. We hypothesize that TnI
level measured on admission could be easy monitored,
independent predictor of infarct size and left ventricle function
Purpose: The purpose of the study was to evaluate which of
the two factors better correlates with LV function and delayed
enhancement volume after successfully treated first ST segment
elevation myocardial infarction (STEMI).
Methods: 34 patients with first anterior STEMI who underwent
successful primary PCI (TIMI III) were included into the study.
Cardiovascular MRI was performed on 1.5 T scanner at
discharge, using 32-channel cardiac coil. Viability was evaluated
on contrast-enhanced images acquired with the use of an
inversion-recovery segmented gradient-echo sequence 20 min-
utes after contrast injection. Infarct size and LV function were
analyzed quantitatively on AW workstation using MASS software.
Results: Mean pain to balloon time was 3.8 ± 2.6 h (ranged
between 1 do 14 h). Median TnI level on admission was 0.6 ng/ml
(ranged between 0.0 and 25.55 ng/ml). Mean LVEF was
40.7% ± 10.9, scar size was 48 ml ± 23 or 31% ± 13.7 as a
percent of LV volume. Linear regression analyses revealed mild
correlation between pain to balloon time and LV EF (R = 0.555;
p < 0.001) and low but statistically significant with infarct size as
a % of LV volume (R = 0.34; p = 0.048). No correlation was
found between TnI level on admission and infarct size or LVEF.
Conclusion: Patients with longer pain to balloon time have
worse LV EF at discharge.
TnI level on admission could not be a predictor of infarct size or
early ejection fraction.
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Background: There is a known link between myocardial
fibrosis as defined by late gadolinium enhancement (LGE),
severity of left ventricular remodeling and ventricular arrhyth-
mias in hypertrophic cardiomyopathy (HCM). Noninvasive
quantification of fibrosis may offer the possibility for risk
stratification. Due to their often diffuse and blurred character
these lesions remain difficult to differentiate from healthy
myocardium in several cases.
Recent studies showed the superiority of Gadobenate dimeglu-
mine (Gd-BOPTA) compared with Gadopentetate dimeglumine
(Gd-DTPA) in distinguishing infarcted from viable myocardium
which can be explained by the higher relaxivity of Gd-BOPTA.
Therefore we hypothesized that Gd-BOPTA may have advantages
over Gd-DTPA for depiction of non-ischemic fibrosis.
Methods: We prospectively enrolled eight Patients with
clinically established HCM and positive LGE during clinical
routine scan with 0.2 mmol/kg Gd-DTPA (0.5 molar). They
underwent a second scan at least 72 hours apart from the first
CMR exam with 0.2 mmol/kg Gd-BOPTA (0.5 molar) using the
same CMR protocol and sequence parameters. None of the
patients had renal failure, coronary artery disease or general
contraindications for CMR.
LGE was assessed in a short axis stack acquired 15 minutes after
contrast administration by using state of the art inversion recovery
gradient echo sequence (slicethickness 6 mm, no gap, TE 5.0 ms, FA
30°, matrix 256 × 192) with a TI adjusted to null signal from normal
myocardium. Positive LGE was judged positive if signal intensity was
above mean + 2 standard deviations of remote myocardium.
Signal intensities of injured myocardium, healthy myocardium, LV
cavity and air were measured in identical locations by using
anatomical landmarks in dedicated software (CMR42, circle
international). Signal to noise ratio (SNR) and contrast to noise
ratio (CNR) were calculated.
Results: We observed no complications relating to contrast
administration. Both the SNR of injured myocardium
(39.1 ± 15.9 vs. 57.7 ± 25.2, p = 0.02) and the CNR between
healthy and injured myocardium (37.2 ± 16.3 vs. 53.0 ± 23.5,
p = 0.021) were significantly higher with Gd-BOPTA. SNR of
LV cavity was significantly higher (56.9 ± 24.3 vs. 119.0 ± 5.8,
p = 0.002) with Gd-BOPTA resulting in a poorer contrast
between injured myocardium and blood which did not affect
the diagnosis since LGE was exclusively non-subendocardial.
Conclusion: Gd-BOPTA improves the visualization of non-
ischemic fibrosis in HCM. This may offer the potential for a more
accurate quantification of focal myocardial fibrosis in this setting.
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Introduction: Although cardiac involvement is an important
prognostic factor in patients with sarcoidosis, cardiac sarcoidosis
(CS) is often difficult to diagnose. Cardiac magnetic resonance
(CMR) imaging with late gadolinium enhancement (LGE) is
considered to be useful in identifying CS early.
Purpose: We investigated LGE characteristics in patients with CS.
Methods: The study included 17 patients who were diagnosed
with CS by Japanese Ministry of Health and Welfare criteria and
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underwent CMR. Among the 17, 15 had LGE and were evaluated
retrospectively. We obtained LGE images (short-axis, vertical long-
axis, and 4-chamber views) using an inversion recovery segmented
gradient-echo sequence 10 minutes after we administered gadoli-
nium-DTPA (0.15 mmol/Kg or 20 mL). We analyzed patterns
(patchy or band-like appearance) and locations of LGE in LV using a
17-segment model. We also assessed the extent of LGE in each
segment of LV (subepicardial, midwall, subendocardial and trans-
mural). We evaluated relationships between LGE characteristics and
LV function using cine MR images.
Results: We observed band-like LGE with distinct margin in 14
patients and patchy LGE in one. The band-like pattern correlated
well with pathological findings in biopsy-proven CS. Transmural
LGE (T-LGE) was observed in 7 patients. All patients with T-LGE
also had subepicardial lesion. In the patients without T-LGE, LGE
was most common in the subepicardial layer (74% of enhanced
segments) and most frequently observed in the basal septal wall,
especially on the RV side. The number of LGE segments of the
patients with T-LGE was significantly larger than that of patients
without T-LGE (14.0 ± 2.0 versus 4.3 ± 3.3 segments,
p < 0.0001). The ejection fraction of the LV (LVEF) of the
patients with T-LGE was significantly lower than that of patients
without T-LGE (19.0 ± 5.9% versus 50.8 ± 6.5%, p < 0.0001),
and the end-diastolic volume of the LV of the patients with T-LGE
was significantly larger than that of patients without T-LGE
(236.4 ± 50.6 versus 96.5 ± 9.7 mL, P < 0.0001).
Conclusion: Characteristic LGE pattern and location allow
accurate diagnosis of CS. CMR with LGE is useful for diagnosing
CS and predicting LV function.
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Objective: The use of Gadofosveset in combination with a
32 channel coil and optimized image sequences allows high
resolution free breathing and ECG triggered imaging of the aortic
arch in patients with coarctation with improved imaging results
compared to previous techniques.
Background: First-pass breath-hold non-ECG-triggered 3D
contrast-enhanced-magnetic-resonance-angiography (CEMRA)
using Gd-DTPA is commonly used for assessment of the aortic
arch. However, image resolution is limited due to time
constraints and vascular borders are blurred due to vascular
motion and insufficient breath holds.
Methods: In 7 patients (30 ± 7 yrs) the aortic arch was imaged
after surgical repair (n = 6) or stent implantation (n = 1) on a 1.5
T clinical scanner (Philips Medical Systems). Patients were
investigated twice within 7 days using Gd-DTPA (day 1, 0.10–
0.17 mmol/kg) and Gadofosveset (day 2, 0.03 mmol/kg). First
pass breath hold 3D CEMRA as well as a respiratory navigator
gated and end-diastolic ECG triggered 3D steady-state free
precession (SSFP) sequence with a T2 prepulse were used.
Gadofosveset allowed the application of an inversion recovery
(IR) prepulse to suppress surrounding tissue signal. Results were
compared (Table 1).
Results: The navigator gated and ECG triggered 3D IR SSFP
(Figure 1C) sequence showed best image quality results (Table 1).
Cross sectional areas showed good interstudy agreement in the
3D SSFP technique without IR (Figure 1B) and 3D first pass
CEMRA (Figure 1A) with similar image quality results using
Gadofosveset and Gd-DTPA. However, these areas are smaller in
end-diastolic ECG triggered respiratory gated sequences
with and without IR prepulse than in breath hold 3D CEMRA
(Table 1, all p < 0.05). Stent artifacts were similar in all
sequences.
Conclusion: A respiratory-navigator-gated and ECG-triggered
3D-IR-SSFP-sequence after application of Gadofosveset
allows free-breathing end-diastolic high-resolution imaging of
the aortic arch in combination with a 32-channel-coil. Image
Table 1 (abstract P261) Values are expressed as mean ± standard deviation
Contrast
Agent
Sequence Contrast to
Noise Ratio (CNR)
Vessel Wall
sharpness (%)
Image quality
(mean ± SD)
Vessel Area (cm2) Isotropic spatial
resolution (mm3)
Gd-DTPA CEMRA 110 ± 10† 41 ± 4† 2.4 ± 0.8† 4.6 ± 1.9† 1.77
SSFP 135 ± 11* 48 ± 6* 3.3 ± 0.5* 4.1 ± 1.7* 1.49
Gadofosveset CEMRA 99 ± 21† 40 ± 4† 2.7 ± 0.5† 4.7 ± 2.1† 1.77
SSFP 128 ± 19* 46 ± 3* 3.1 ± 0.7* 4.1 ± 1.6* 1.49
SSFP+IR 154 ± 14 53 ± 5 3.7 ± 0.5 3.9 ± 1.7 1.49
†,*, no significant differences between corresponding sequences (Gd-DTPA vs Gadofosveset). Image quality: 1 = non diagnostic, 2 = diagnostic,
3 = good, 4 = excellent.
Figure 1 (abstract P261)
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